← 產業報告目錄
Clinical Trial Planning and Design Services Market Size, Share & Trends Analysis Report By Trial Phase, By Therapeutic Area (Oncological Disorders, Cardiovascular Disorders, Inflammatory Disorders, Neurological Disorders, Other Therapeutic Areas), By Service, By Region, And by Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-21頁數 180報告編號 INSIGHTACE-1f677af52e
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Clinical Trial Planning and Design Services Market is positioned for steady expansion, with a projected CAGR of 9.0% from 2025 to 2034.
Clinical Trial Planning and Design Services covers key industry insights & findings from the report:
Due to advances in research and medical technology, clinical trials are becoming escalatingly complex. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is supported by escalating need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Trial Planning and Design Services Market Snapshot
Chapter 4. Global Clinical Trial Planning and Design Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Trial Phases Estimates & Trend Analysis
5.1. By Trial Phases & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Trial Phases:
5.2.1. Phase I
5.2.2. Phase II
5.2.3. Phase III
5.2.4. Phase IV
Chapter 6. Market Segmentation 2: By Therapeutic Area Estimates & Trend Analysis
6.1. By Therapeutic Area & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Therapeutic Area:
6.2.1. Oncological Disorders
6.2.2. Cardiovascular Disorders
6.2.3. Inflammatory Disorders
6.2.4. Neurological Disorders
6.2.5. Other Therapeutic Areas
Chapter 7. Market Segmentation 3: By Service Estimates & Trend Analysis
7.1. By Service & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Service:
7.2.1. Statistical Analysis Plan
7.2.2. eCRF
7.2.3. Site Identification and Selection
7.2.4. Medical Writing
7.2.5. Other Services
Chapter 8. Clinical Trial Planning and Design Services Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Trial Phases, 2021-2034
8.1.2. North America Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
8.1.3. North America Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Service, 2021-2034
8.1.4. North America Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Trial Phases, 2021-2034
8.2.2. Europe Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
8.2.3. Europe Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Service, 2021-2034
8.2.4. Europe Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Trial Phases, 2021-2034
8.3.2. Asia Pacific Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
8.3.3. Asia-Pacific Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Service, 2021-2034
8.3.4. Asia Pacific Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Trial Phases, 2021-2034
8.4.2. Latin America Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
8.4.3. Latin America Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Service, 2021-2034
8.4.4. Latin America Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Trial Phases, 2021-2034
8.5.2. Middle East & Africa Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
8.5.3. Middle East & Africa Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by Service, 2021-2034
8.5.4. Middle East & Africa Clinical Trial Planning and Design Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Atlantia Clinical Trials
9.2.2. PharmaLex
9.2.3. Emergo UL
9.2.4. ICON plc
9.2.5. Cytel
9.2.6. Health Policy Associate
9.2.7. CD BioSciences
9.2.8. LLX Solutions
9.2.9. SGS
9.2.10. ADM Korea
9.2.11. McDougall Scientific
9.2.12. ClinAsia
9.2.13. BioPoint
9.2.14. IQVIA
9.2.15. PPD, Inc.
9.2.16. Veristat, LLC
9.2.17. Clinical Accelerator
9.2.18. Allied Clinical Management GmbH
9.2.19. Parexel International Corporation
9.2.20. Pepgra
9.2.21. WIRB-Copernicus Group
9.2.22. Afortiori Development Ltd
9.2.23. Celerion
9.2.24. CCS (Cardiovascular Clinical Sciences)
9.2.25. MCRA
9.2.26. dicentra
9.2.27. DOT WORLD (Japan)
9.2.28. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們